Funding for this research was provided by:
National Cancer Institute (P01 CA165995)
Text and Data Mining valid from 2019-08-13
Received: 6 January 2019
Accepted: 30 July 2019
First Online: 13 August 2019
Ethics approval and consent to participate
: The Clinical Studies Review Committee (CSRC) at the Cummings School of Veterinary Medicine and IACUC at Tufts University approved this study. Written informed consent was obtained from owners prior to clinical trial enrollment.
: Not applicable.
: Oclacitinib was provided by Zoetis for this clinical trial. CAL has received honoraria in the past from Zoetis. CAL is a member of the BMC Veterinary Research Editorial Board (Associate Editor). She had no role in the handling of this manuscript.